molecular remission for relapsed patients with CML, 5 although some suffered severe GVHD and/or pancytopenia. 6 Discontinuation of immunosuppression has also A 46-year-old woman with Ph-positive CML received an unmanipulated BMT from an HLA-identical been reported to suppress leukemia, 7 but its response varies from case to case. We report here a patient with CML who brother, conditioned with busulfan-cyclophosphamide. Five months after BMT, cytogenetic relapse occurred, relapsed cytogenetically after allogeneic BMT, and attained a complete cytogenetic response after CsA discontinuation. and CsA was decreased and then discontinued. Mild acute GVHD occurred, but gradually improved with no Graft failure occurred at the time of the relapse, and the patient recovered host-derived normal hematopoiesis immunosuppression. Forty days after CsA discontinuation, both cytogenetic and fluorescence in situ hybridiz-(46,XX). ation analyses showed a host-derived normal karyotype, 46,XX, and no evidence of leukemic cells or donor graft. The sustained host-derived hematopoiesis lasted for 2 Case report years until sudden recurrence of CML. In this case, the discontinuation of CsA led to GVHD and also sup-A 46-year-old woman referred to Aichi Cancer Center was diagnosed with CML in chronic phase in November 1993. pression of the relapsed leukemia, presumably by a 'specific' GVL effect. There was also graft failure. The
or buffy coat harvest. Therefore, CsA was reduced from Discussion 280 mg/day p.o. to 140 mg/day for 2 weeks and then discontinued in anticipation of a graft-versus-leukemia (GVL)
The optimal treatment for patients with leukemia recureffect. Two weeks after the discontinuation of CsA, she rence after bone marrow transplantation remains unknown. developed systemic skin erythema and a maculopapular Recently, adoptive immunotherapy with DLI has been tried rash, and was diagnosed with acute GVHD by skin biopsy on relapsed CML patients, and has induced remission in a on day 230. Mild rheumatoid-like arthralgia and fever considerable number of cases, although severe GVHD exceeding 38°C observed, were also considered to be maniand/or pancytopenia have been noted. 6 In our case, disconfestations of GVHD. All the symptoms gradually resolved tinuation of CsA resulted in a complete cytogenetic by day 300 without further immunosuppression. Urticariaresponse. Interestingly, rejection of the donor cells and like skin eruptions, also diagnosed as GVHD on skin recovery of host-derived hematopoiesis with a normal biopsy, were intermittently present for 6 months after diskaryotype (46,XX) were observed simultaneously. continuation of CsA. The pancytopenia also resolved; the In this case, suppression of the leukemic clone with a WBC count reached 4.0 × 10 9 /l on day 284, and the platelet cytogenetic response after CsA discontinuation was count 50.0 × 10 9 /l on day 420. Cytogenetic analysis accompanied by GVHD, suggesting that it was associated revealed normal host metaphases of (46,XX), and no donor with a GVL effect rather than an autologous anti-leukemic cells, and interphase fluorescence in situ hybridization effect mediated by host lymphocytes. Recently, Wakui et (FISH) analysis revealed no detectable signal by the Y al 8 reported a post-BMT CML case who regained complete chromosome-specific probe (Table 1) . Donor lymphocytes host-derived hematopoiesis with a durable molecular were also undetectable by cytogenetic analysis using phyremission. 8 However, mixed T cell chimerism in the periphtohemagglutinin (PHA)-stimulated peripheral blood monoeral blood was noted. In our case, although GVHD was nuclear cells. Interphase FISH analysis still revealed the observed for approximately 6 months after discontinuation BCR-ABL fusion signal on day 276, but the signal subof CsA, donor-derived lymphocytes probably existed but sequently decreased and became undetectable by day 448.
were not detectable by interphase FISH analysis. GVHD She maintained normal hematopoiesis of host origin for improved gradually, and donor-derived lymphocytes 2 years thereafter. On day 958, her WBC count abruptly remained undetectable by FISH analysis, suggesting comincreased to 79.0 × 10 9 /l with 73% leukemic blasts, and the plete rejection of the donor graft, including lymphocytes. platelet count fell to 17.0 × 10 9 /l. FISH and cytogenetic Finally, leukemic recurrence occurred. The disappearance analysis revealed a Ph-positive karyotype, indicating recurof donor-derived lymphocytes might have contributed to rence (blast crisis) of CML. She did not attain remission leukemic relapse in our case, in contrast to the case reported with chemotherapy or interferon therapy after the blast by Wakui et al. radiation accident victim exposed to about 10-Gy acute 2462-2465. total body irradiation, partial but sustained hematopoietic
